Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Clinical trial NCT04655092 · RECRUITING

Trial details

NCT number: NCT04655092
Sponsor: PharmaEssentia Japan K.K.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Polycythemia Vera (PV)

Start date: 2021-01-19
Primary completion: 2026-06-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.